EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Transarterial chemoembolization combined with sintilimab and lenvatinib for the treatment of unresectable hepatocellular carcinoma: a retrospective study

Chenyu Shen, Wenxi Jiang, Ruiqing Chen, Lingbing Li, Yunbo Wu, Long Tan, Yadong Chen, Weiqiang Zhang, Zhijun Wang

Journal of Cancer Research and Clinical Oncology · 2024

DOI: 10.1007/s00432-024-05949-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cancer Research and Clinical Oncology, 2024. Verfasst von Chenyu Shen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatric Medicine & National Clinical Research Centre of Geriatric Disease, The Second Medical Center, Chinese PLA General Hospital, N…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Quinolines, Chemoembolization, Therapeutic. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Military Health Special Research Funding, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsQuinolinesChemoembolization, TherapeuticPhenylurea CompoundsAntibodies, Monoclonal, HumanizedAntineoplastic Combined Chemotherapy ProtocolsHumansMaleRetrospective StudiesMiddle AgedFemaleAgedAdult

Stichwörter der Autor:innen

Combination therapyLenvatinibSintilimabTACEUnresectable hepatocellular carcinoma

Substanzen

lenvatinibQuinolinesPhenylurea CompoundssintilimabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Geriatric Medicine & National Clinical Research Centre of Geriatric Disease, The Second Medical Center, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing, 100853, China.
  • Department of Interventional Radiology, Chinese PLA General Hospital, Beijing, 100853, China.
  • Health Service Department of the Guard Bureau of the General Office of the Central Committee of the Communist Party of China, No. 15 Wenjin Street, Xicheng District, Beijing, 100017, China.
  • Health Service Department of the Guard Bureau of the General Office of the Central Committee of the Communist Party of China, No. 15 Wenjin Street, Xicheng District, Beijing, 100017, China. chenyadongddd@outlook.com.
  • Health Service Department of the Guard Bureau of the General Office of the Central Committee of the Communist Party of China, No. 15 Wenjin Street, Xicheng District, Beijing, 100017, China. zhangweiqiangmmwq@126.com.
  • Department of Geriatric Medicine & National Clinical Research Centre of Geriatric Disease, The Second Medical Center, Chinese PLA General Hospital, No. 28 Fuxing Road, Haidian District, Beijing, 100853, China. zhijun_wa…

Förderung

  • Military Health Special Research Funding
  • National Natural Science Foundation of China

Zitieren

APA

Shen, C., Jiang, W., Chen, R., Li, L., Wu, Y., Tan, L., Chen, Y., Zhang, W., & Wang, Z. (2024). Transarterial chemoembolization combined with sintilimab and lenvatinib for the treatment of unresectable hepatocellular carcinoma: a retrospective study. Journal of Cancer Research and Clinical Oncology. https://doi.org/10.1007/s00432-024-05949-2

Vancouver

Shen C, Jiang W, Chen R, Li L, Wu Y, Tan L, et al. Transarterial chemoembolization combined with sintilimab and lenvatinib for the treatment of unresectable hepatocellular carcinoma: a retrospective study. Journal of Cancer Research and Clinical Oncology. 2024. doi:10.1007/s00432-024-05949-2

BibTeX
@article{Shen2024,
  author = {Shen, Chenyu and Jiang, Wenxi and Chen, Ruiqing and Li, Lingbing and Wu, Yunbo and Tan, Long and Chen, Yadong and Zhang, Weiqiang and Wang, Zhijun},
  title = {Transarterial chemoembolization combined with sintilimab and lenvatinib for the treatment of unresectable hepatocellular carcinoma: a retrospective study},
  journal = {Journal of Cancer Research and Clinical Oncology},
  year = {2024},
  doi = {10.1007/s00432-024-05949-2}
}
Kostenlos starten →